Skysun Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 2.00 M
as on 17-11-2024
- Paid Up Capital ₹ 1.96 M
as on 17-11-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 8.10 M
as on 17-11-2024
- Satisfied Charges ₹ 1.27 Cr
as on 17-11-2024
- Revenue 3.54%
(FY 2023)
- Profit 96.67%
(FY 2023)
- Ebitda 3.33%
(FY 2023)
- Net Worth 9.93%
(FY 2023)
- Total Assets 7.73%
(FY 2023)
About Skysun Lifesciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 M and a paid-up capital of Rs 1.96 M.
The company currently has active open charges totaling ₹8.10 M. The company has closed loans amounting to ₹1.27 Cr, as per Ministry of Corporate Affairs (MCA) records.
Mritunjay Singh, Amit Singh, Gayatri Patel, and Four other members serve as directors at the Company.
- CIN/LLPIN
U24233GJ2013PTC076245
- Company No.
076245
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Jul 2013
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Skysun Lifesciences?
Board Members(7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mritunjay Singh  | Director | 01-Jul-2014 | Current |
| Amit Singh | Director | 28-Jul-2014 | Current |
| Gayatri Patel | Director | 12-Dec-2016 | Current |
| Pinki Sadhu | Director | 26-Mar-2015 | Current |
| Artiben Kurmi | Director | 16-Jan-2015 | Current |
| Leena Malhotra | Director | 16-Jan-2015 | Current |
Financial Performance of Skysun Lifesciences.
Skysun Lifesciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 3.54% increase. The company also saw a substantial improvement in profitability, with a 96.67% increase in profit. The company's net worth moved up by a moderate rise of 9.93%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Skysun Lifesciences?
In 2023, Skysun Lifesciences had a promoter holding of 42.86% and a public holding of 57.14%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Skycure Lifesciences Private LimitedActive 10 years 7 daysMritunjay Singh, Amit Singh and 2 more are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 24 Jan 2024 | ₹8.10 M | Open |
Others Creation Date: 29 Jun 2019 | ₹7.21 M | Satisfied |
The Kalupur Commercial Co-Operative Bank Limited Creation Date: 14 Jun 2018 | ₹3.00 M | Satisfied |
How Many Employees Work at Skysun Lifesciences?
Skysun Lifesciences has a workforce of 17 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Skysun Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Skysun Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
